SCHEMBL31061981

SCHEMBL31061981

NCCc1ccc2ccoc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.53
CHRM1 P11229 2/20 0.53
CHRM3 P20309 2/20 0.53
HTR1B P28222 4/20 0.50
TAAR1 Q96RJ0 4/20 0.42
KDM4E B2RXH2 4/20 0.42
ADRA2A P08913 2/20 0.42
MAPT P10636 2/20 0.42
DRD2 P14416 2/20 0.42
DRD1 P21728 2/20 0.42
DRD4 P21917 2/20 0.42
DRD5 P21918 2/20 0.42
SLC6A2 P23975 2/20 0.42
MAPK1 P28482 2/20 0.42
DRD3 P35462 2/20 0.42
RECQL P46063 2/20 0.42
SLC6A3 Q01959 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP2D6 P10635 2/20 0.42
HSD17B10 Q99714 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14756115 1.00 CHRM2 (0.53) CHRM2CHRM1CHRM3HTR1BTAAR1
Hydrochloric Acid SCHEMBL20563057 0.98 CHRM2 (0.51) CHRM2CHRM1CHRM3HTR1BTAAR1
SCHEMBL4451104 0.85 HTR1B (0.50) HTR1BTAAR1KDM4EADRA2AMAPT
SCHEMBL507041 0.84 HTR1B (0.53) CHRM2CHRM1CHRM3HTR1BTAAR1
SCHEMBL3794299 0.81 CHRM2 (0.56) CHRM2CHRM1CHRM3HTR1BKDM4E
SCHEMBL10245596 0.78 HTR1B (0.59) CHRM2CHRM1CHRM3HTR1BTAAR1
SCHEMBL2090147 0.78 CHRM2 (0.55) CHRM2CHRM1CHRM3HTR1BKDM4E
SCHEMBL3797578 0.78 CHRM2 (0.58) CHRM2CHRM1CHRM3HTR1BMAPK1
SCHEMBL25235422 0.77 CHRM2 (0.60) CHRM2CHRM1CHRM3HTR1BKDM4E
SCHEMBL13230585 0.77 HTR1B (0.58) CHRM2CHRM1CHRM3HTR1BKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208992-A1 MACROCYCLES AS CFTR MODULATORS CFTR, PKD1, ARRB1 CHRM2 116/4885CHRM1 180/4885CHRM3 114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.